Demographics

Unpacking the triumph of ageing

  • 07 January 2019
  • 5 min read

For much of the past 200 years, improved life expectancies were the result of reductions in death rates of those in early and middle age. But, in recent decades, there  has been a shift to improving and lengthening the lives of those who are older, which implies that ageing is a more malleable process than previously thought. In this video,  Dani Saurymper, portfolio manager and research lead for Longevity at AXA IM Framlington Equities and Emeritus Professor Thomas Kirkwood Associate Dean for Ageing at the University of Newcastle discuss the triumph of ageing, the science behind it and the impacts it is having on society at large.

Related Articles

Demographics

Boomers are going to drive a silver surge

  • 03 September 2021
  • 5 min read
Demographics

The expanding middle class: why global affluence is a developing trend

  • 17 August 2021
  • 10 min read
Demographics

What investors need to know about the longevity economy

  • 03 August 2021
  • 5 min read

    Disclaimer

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

    This document has been edited by AXA INVESTMENT MANAGERS SA, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6 place de la Pyramide, 92800 Puteaux, registered with the Nanterre Trade and Companies Register under number 393 051 826. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.

    In the UK, this document is intended exclusively for professional investors, as defined in Annex II to the Markets in Financial Instruments Directive 2014/65/EU (“MiFID”). Circulation must be restricted accordingly.